Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
Open accessThe DOI matches its Crossref record; 49 of the 50 references it cites were found in a registry or an index.
Abstract
Nonalcoholic fatty liver disease (NAFLD) is characterized by the accumulation of excess liver triacylglycerol (TAG), inflammation, and liver damage. The goal of the present study was to directly quantify the biological sources of hepatic and plasma lipoprotein TAG in NAFLD. Patients (5 male and 4 female; 44 +/- 10 years of age) scheduled for a medically indicated liver biopsy were infused with and orally fed stable isotopes for 4 days to label and track serum nonesterified fatty acids (NEFAs), dietary fatty acids, and those derived from the de novo lipogenesis (DNL) pathway, present in liver tissue and lipoprotein TAG. Hepatic and lipoprotein TAG fatty acids were analyzed by gas chromatography/mass spectrometry. NAFLD patients were obese, with fasting hypertriglyceridemia and hyperinsulinemia. Of the TAG accounted for in liver, 59.0% +/- 9.9% of TAG arose from NEFAs; 26.1% +/- 6.7%, from DNL; and 14.9% +/- 7.0%, from the diet. The pattern of labeling in VLDL was similar to that in liver, and throughout the 4 days of labeling, the liver demonstrated reciprocal use of adipose and dietary fatty acids. DNL was elevated in the fasting state and demonstrated no diurnal variation. These quantitative metabolic data document that both elevated peripheral fatty acids and DNL contribute to the accumulation of hepatic and lipoprotein fat in NAFLD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Sarcopenic obesity seems to impair insulin signaling in hepatocytes, resulting in increased de novo hepatic lipogenesis and inhibited hepatic β-oxidation [141].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [141]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Of note, although the major source of hepatocellular triglycerides are adipose tissue-derived NEFA, the rate of hepatic de novo lipogenesis is also much greater in MASLD, further contributing to intrahepatic lipid accumulation [17].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [17]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Remarkably, the major fraction of hepatocellular triglycerides in people with obesity and MASLD is not derived from non-esterified fatty acids (NEFA) provided by dietary lipids, but from circulating NEFA released from adipose tissue [17].”
From Obesity and MASLD: Is weight loss the (only) key to treat metabolic liver disease? (2024) · cites this paper as [17]
In the citing paper
“In individuals with MASLD and obesity, hepatic TG is reported to derive approximately 59% from circulating FFAs, 26% from DNL, and 15% from dietary sources [67].”
From Hepatic Insulin Resistance and Steatosis in Metabolic Dysfunction-Associated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications (2025) · cites this paper as [67]
In the citing paper
“IHTG was composed mainly of FFAs from SAT lipolysis (∼60%) and, to a lesser extent, FFAs from DNL (∼25%) or diet (∼15%).”
From Lipid metabolism in MASLD and MASH: From mechanism to the clinic (2024) · cites this paper as [23]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A SIMPLE METHOD FOR THE ISOLATION AND PURIFICATION OF TOTAL LIPIDES FROM ANIMAL TISSUES
Folch, J., Lees, M., & Stanley, G. H. S. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64849-5 · Cited by 65,189
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Toprak, O., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney and Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,627
SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15593 · Cited by 4,794 · cited 1×
“Given previous observations of higher fed-state DNL (23) and the known stimulatory effect of insulin on fatty acid synthesis (24), we were surprised that fed-state lipogenesis assessed at 1500 in tTRL TAG did not differ from values obtained in the fasting Figure 1 Model of lipid flux through the liver.”
ResultSREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215593 · Cited by 4,092
Ludwig, J., Viggiano, T. R., McGill, D. B., & Ott, B. J. (1980) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(24)00530-5 · Cited by 2,903
Nonalcoholic Fatty Liver Disease
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., McCullough, A. J., Natale, S., Forlani, G., & Melchionda, N. (2001) · Diabetes · doi:10.2337/diabetes.50.8.1844 · Cited by 2,581
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · cited 2×
“Insulin resistance has been shown to be associated with dysregulation of adiposederived fatty acid flux in the fasting state (10–12), and strong evidence exists demonstrating that in NAFLD patients, insulin does not suppress adipose tissue lipolysis to the same extent that it does in healthy individuals (13).”
BackgroundAssociation of nonalcoholic fatty liver disease with insulin resistance
Marchesini, G., Brizi, M., Morselli-Labate, A. M., Bianchi, G., Bugianesi, E., McCullough, A. J., Forlani, G., & Melchionda, N. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00271-5 · Cited by 1,568
Dixon, J. B., Bhathal, P. S., & O'Brien, P. E. (2001) · Gastroenterology · doi:10.1053/gast.2001.25540 · Cited by 1,360 · cited 6×
“Dixon, J.B., Bhathal, P.S., and O’Brien, P.E. 2001.”
Influential
Research works printed but not linked: 6
- Donnelly, 2004, Diabetes., 56, A53
- 10.2337/diabetes.53.3.521 · DOI · Paper page
- Barrows, 2004, Diabetes., 56, A1388
- Timlin, 2004, Diabetes., 56, A338
- Baar, 2005, Am. J. Physiol., 288, E187
- Hellerstein, 1993, Am. J. Physiol., 265, E814
Cited by
Items 901–1,000 of 1,038
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
Wang, X., Cao, Y., Fu, Y., Guo, G., & Zhang, X. (2011) · Lipids in Health and Disease · doi:10.1186/1476-511x-10-234 · Cited by 87
“Most of the published literature has focused on triglycerides accumulation as the key defect in NAFLD [6,7].”
BackgroundTCDD-Elicited Effects on Liver, Serum, and Adipose Lipid Composition in C57BL/6 Mice
Angrish, M. M., Dominici, C. Y., & Zacharewski, T. R. (2012) · Toxicological Sciences · doi:10.1093/toxsci/kfs277 · Cited by 80
“It is characterized by dyslipidemia, obesity, and increased hepatic triacylglyceride (TAG) levels (Cheung and Sanyal, 2010; Donnelly et al., 2005).”
BackgroundRole of β-adrenergic receptors in regulation of hepatic fat accumulation during aging
Ghosh, P., Shu, Z.-J., Zhu, B., Lu, Z., Ikeno, Y., Barnes, J. L., Yeh, C., Zhang, B.-X., Katz, M. S., & Kamat, A. (2012) · Journal of Endocrinology · doi:10.1530/joe-11-0406 · Cited by 74
Nutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data
Yki-Järvinen, H. (2010) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32833f4b34 · Cited by 71
Application of metabolomics technologies toward cancer prognosis and therapy
Hoang, G., Udupa, S., & Le, A. (2019) · International review of cytology · doi:10.1016/bs.ircmb.2019.07.003 · Cited by 79
Sun, W., Liu, P., Wang, T., Wang, X., Zheng, W., & Li, J. (2020) · Food & Function · doi:10.1039/c9fo02237f · Cited by 75
Quantitative flux analysis in mammals
Bartman, C. R., TeSlaa, T., & Rabinowitz, J. D. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00419-2 · Cited by 70
Jia, L., Ma, Y., Rong, S., Betters, J. L., Xie, P., Chung, S., Wang, N., Tang, W., & Yu, L. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006353 · Cited by 73
Long‐TE 1H MRS suggests that liver fat is more saturated than subcutaneous and visceral fat
Lundbom, J., Hakkarainen, A., Söderlund, S., Westerbacka, J., Lundbom, N., & Taskinen, M. (2011) · NMR in Biomedicine · doi:10.1002/nbm.1580 · Cited by 70
“(24) used stable isotope labeling and found that themajority of FAs in liver TGs are derived from the plasma pool of NEFAs,”
Haufe, S., Haas, V., Utz, W., Birkenfeld, A. L., Jeran, S., Böhnke, J., Mähler, A., Luft, F. C., Schulz-Menger, J., Boschmann, M., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0102 · Cited by 72
“Approximately 80% of liver fatty acids originate from circulating fatty acids (32) that are mobilized predominantly from adipose tissue.”
BackgroundInsulin Regulates Hepatic Triglyceride Secretion and Lipid Content via Signaling in the Brain
Scherer, T., Lindtner, C., O’Hare, J., Hackl, M., Zielinski, E., Freudenthaler, A., Baumgartner-Parzer, S., Tödter, K., Heeren, J., Krššák, M., et al. (2016) · Diabetes · doi:10.2337/db15-1552 · Cited by 66
“This is likely explained by the finding that brain insulin signaling also increases FA uptake into WAT, at least in C57Bl/6J mice (42).”
BackgroundKim, J., Carlson, M. E., Kuchel, G. A., Newman, J. W., & Watkins, B. A. (2016) · International Journal of Obesity · doi:10.1038/ijo.2015.135 · Cited by 73
Dludla, P. V., Nkambule, B. B., Mazibuko-Mbeje, S. E., Nyambuya, T. M., Marcheggiani, F., Cirilli, I., Ziqubu, K., Shabalala, S. C., Johnson, R., Louw, J., et al. (2020) · Antioxidants · doi:10.3390/antiox9121283 · Cited by 78
“Abbreviations: TG = triglycerides; DNL = de novo lipogenesis.”
BackgroundInfluentialLipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis
Branković, M., Jovanović, I., Dukić, M., Radonjić, T., Oprić, S., Klašnja, S., & Zdravkovic, M. D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23095146 · Cited by 78
“Triglycerides and cholesterol take the highest percentage in the construction of them [36,37].”
BackgroundMusso, G., Saba, F., Cassader, M., & Gambino, R. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101238 · Cited by 74
Sitagliptin attenuates methionine/choline-deficient diet-induced steatohepatitis
Jung, Y., Choi, Y., Jung, G., Seo, H.-Y., Kim, H., Jang, B. K., Kim, J., Lee, I., Kim, M. K., & Park, K. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.04.028 · Cited by 76
“[24] Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ.”
BackgroundIs liver fat detrimental to vessels?: intersections in the pathogenesis of NAFLD and atherosclerosis
Loria, P., Lonardo, A., & Targher, G. (2008) · Clinical Science · doi:10.1042/cs20070311 · Cited by 72
Nonalcoholic Fatty Liver Disease
Paredes, A. H., Torres, D. M., & Harrison, S. A. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.03.005 · Cited by 76
Magkos, F. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.02.003 · Cited by 83
Yoshimura, E., Kumahara, H., Tobina, T., Matsuda, T., Ayabe, M., Kiyonaga, A., Anzai, K., Higaki, Y., & Tanaka, H. (2014) · Journal of Obesity · doi:10.1155/2014/197216 · Cited by 70
“reported that dietary fatty acids did not contribute significantly to the sources of liver triglycerides in subjects with NAFLD (dietary fatty acids 15%, serum nonesterified fatty acids 59%, and de novo lipogenesis 26%) [37].”
BackgroundLambert, J. E., Parnell, J. A., Eksteen, B., Raman, M., Bomhof, M. R., Rioux, K. P., Madsen, K. L., & Reimer, R. A. (2015) · BMC Gastroenterology · doi:10.1186/s12876-015-0400-5 · Cited by 72
“Unrestrained free fatty acid flux from adipose tissue has been implicated as a primary contributor to steatosis [10, 11], however recent work has indicated that de novo lipogenesis is significantly elevated in NAFLD patients and contributes to both plasma and hepatic fatty acid levels [12–14].”
BackgroundDual-5α-Reductase Inhibition Promotes Hepatic Lipid Accumulation in Man
Hazlehurst, J. M., Oprescu, A. I., Nikolaou, N., Di Guida, R., Grinbergs, A. E. K., Davies, N. P., Flintham, R. B., Armstrong, M. J., Taylor, A. E., Hughes, B. A., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2928 · Cited by 71
GLP-1 receptor agonists in NAFLD
Petit, J.-M., & Vergès, B. L. (2017) · Diabetes & Metabolism · doi:10.1016/s1262-3636(17)30070-8 · Cited by 77
Liver X Receptor: an oxysterol sensor and a major player in the control of lipogenesis
Ducheix, S., Lobaccaro, J. A., Martin, P. G. P., & Guillou, H. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.06.004 · Cited by 75
“A better understanding of the role of LXR n the control of hepatic lipogenesis is a major issue as increased FA ynthesis has been shown to contribute to the progression of non lcoholic fatty liver disease (NAFLD) (Donnelly et al., 2005).”
Bellanti, F., Villani, R., Tamborra, R., Blonda, M., Iannelli, G., di Bello, G., Facciorusso, A., Poli, G., Iuliano, L., Avolio, C., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.11.016 · Cited by 73
“accumulation as pathogenic factor [26,27].”
Lipodystrophy: A paradigm for understanding the consequences of "overloading" adipose tissue
Lim, K., Haider, A., Adams, C., Sleigh, A., & Savage, D. B. (2020) · Physiological Reviews · doi:10.1152/physrev.00032.2020 · Cited by 111
Roy, D., & Tedeschi, A. (2021) · Cells · doi:10.3390/cells10051078 · Cited by 68
von Loeffelholz, C., Coldewey, S. M., & Birkenfeld, A. L. (2021) · Cells · doi:10.3390/cells10071822 · Cited by 73
“After a meal circulating FFA acco nt for ~60% and DNL for 25–30% of excess liver triacylglycerol storage, while dietary lipids range as negligible contributors ([2,135],”
BackgroundInfluentialChoi, W. G., Choi, W., Oh, T. J., Cha, H.-N., Hwang, I., Lee, Y. K., Lee, S. Y., Shin, H., Lim, A., Ryu, D., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci145331 · Cited by 76
“In quantitative terms, 60% of triglycerides (TGs) in the livers of patients with NAFLD originates from WAT (27).”
BackgroundArmstrong, M. J., Hazlehurst, J. M., Hull, D., Guo, K., Borrows, S., Yu, J., Gough, S. C., Newsome, P. N., & Tomlinson, J. W. (2014) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12272 · Cited by 69
“Recent studies have recognized the importance of adipose tissue, as the principal source of fatty acids (≈60%) for the liver, in driving lipid synthesis in both healthy individuals [10] and NASH patients [11].”
Mitochondria and Redox Signaling in Steatohepatitis
Morris, E. M., Rector, R. S., Thyfault, J. P., & Ibdah, J. A. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3795 · Cited by 72
“Importantly, human stable isotope studies have documented the involvement of increased de novo lipogenesis in the development of FLD (46, 47).”
Does Vitamin C Deficiency Promote Fatty Liver Disease Development?
Ipsen, D. H., Tveden‐Nyborg, P., & Lykkesfeldt, J. (2014) · Nutrients · doi:10.3390/nu6125473 · Cited by 77
“Thus, a vicious cycle is established: Adipocyte dysfunction induces a low-grade inflammation, which increases the release of FFA.”
BackgroundInfluentialHepatic Steatosis and Increased Adiposity in Mice Consuming Rapidly vs. Slowly Absorbed Carbohydrate
Scribner, K. B., Pawlak, D. B., & Ludwig, D. S. (2007) · Obesity · doi:10.1038/oby.2007.260 · Cited by 69
Sphingolipid Metabolism and Obesity-Induced Inflammation
Kang, S. C., Kim, B.-R., Lee, S., & Park, T. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00067 · Cited by 81
“Obesity-induced FFA increase in plasma contributes to approximately 60% of accumulated TAG in the livers of NAFLD patients (Donnelly et al., 2005).”
BackgroundHodson, L., McQuaid, S., Humphreys, S. M., Milne, R. W., Fielding, B. A., Frayn, K. N., & Karpe, F. (2010) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00272.2010 · Cited by 74
“Recently, various models of postprandial lipemia have been used to investigate the contributions of fatty acids to TRL-TG (2, 11, 44) and VLDL-TG (24, 25).”
Hepatic steatosis does not cause insulin resistance in people with familial hypobetalipoproteinaemia
Visser, M. E., Lammers, N. M., Nederveen, A. J., van der Graaf, M., Heerschap, A., Ackermans, M. T., Sauerwein, H. P., Stroes, E. S., & Serlie, M. J. (2011) · Diabetologia · doi:10.1007/s00125-011-2157-x · Cited by 69
“NAFLD is the result of hepatic fat accumulation due to an increased flux of NEFA through the portal vein, reduced hepatic fatty acid oxidation and increased hepatic de novo lipogenesis, all of which are associated with central obesity and insulin resistance [3].”
BackgroundCREBH-FGF21 axis improves hepatic steatosis by suppressing adipose tissue lipolysis
Park, J.-G., Xu, X., Cho, S., Hur, K. Y., Lee, M.-S., Kersten, S., & Lee, A.-H. (2016) · Scientific Reports · doi:10.1038/srep27938 · Cited by 71
Della Pepa, G., Vetrani, C., Lombardi, G., Bozzetto, L., Annuzzi, G., & Rivellese, A. (2017) · Nutrients · doi:10.3390/nu9101065 · Cited by 68
“clearly observed that 59% of the triglycerides present in the liver of patients with NAFLD derived from free fatty acids released from adipose tissue, 26% from de novo lipogenesis, and 15% from dietary lipids [19].”
BackgroundFatty acids in non-alcoholic steatohepatitis: Focus on pentadecanoic acid
Yoo, W., Gjuka, D., Stevenson, H. L., Song, X., Shen, H., Yoo, S. Y., Wang, J., Fallon, M. B., Ioannou, G. N., Harrison, S. A., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0189965 · Cited by 77
Osteocalcin protects against nonalcoholic steatohepatitis in a mouse model of metabolic syndrome
Gupte, A. A., Sabek, O. M., Fraga, D., Minze, L. J., Nishimoto, S. K., Liu, J. Z., Afshar, S., Gaber, L., Lyon, C. J., Gaber, A. O., et al. (2014) · Endocrinology · doi:10.1210/en.2014-1430 · Cited by 70
“and adipose tissue lipolysis (59%) (30).”
A novel chicken model of fatty liver disease induced by high cholesterol and low choline diets
Lin, C.-W., Huang, T.-W., Peng, Y., Lin, Y., Mersmann, H. J., & Ding, S. (2020) · Poultry Science · doi:10.1016/j.psj.2020.11.046 · Cited by 75
“The excess circulating free fatty acid from adipose tissue can be stored in the livers (Donnelly et al., 2005; Bril et al., 2017;Polyzos et al., 2017).”
BackgroundThe influence of PM2.5 exposure on non-alcoholic fatty liver disease
Chen, J., Wu, L., Yang, G., Zhang, C., Liu, X., Sun, X., Chen, X., & Wang, N. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119135 · Cited by 75
Zhou, J., Zhang, N., Aldhahrani, A., Soliman, M. M., Zhang, L., & Zhou, F. L. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.956688 · Cited by 82
“The results of the study showed that 26% of TG in the liver of NAFLD patients were synthesized from de novo fatty acids (10).”
Falkevall, A., Mehlem, A., Folestad, E. B., Ning, F. C., Osorio-Conles, Ó., Radmann, R., de Hollanda, A., Wright, S. D., Scotney, P. D., Nash, A. D., et al. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.01.014 · Cited by 72
Jiang, J., Gao, Y., Wang, J., Huang, Y., Yang, R., Zhang, Y., Ma, Y., Wen, Y., Luo, G., Zhang, S., et al. (2025) · Cell Metabolism · doi:10.1016/j.cmet.2025.01.016 · Cited by 77
Zhou, X., Chen, J., Chen, J., Wu, W.-C., Wang, X., & Wang, Y. (2015) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2015.08.014 · Cited by 75
“Free fatty acids' (FFAs) influx from adipose tissue, due to uncontrolled lipolysis under the situation of insulin resistance, contributes to approximately 60% of liver triglycerides (TG) and plays a causal role in the development of obesity-related steatohepatitis in NAFLD [4,5].”
BackgroundSafety of High Volume Lipid Emulsion Infusion
Hiller, D., Gregorio, G. D., Kelly, K., Ripper, R. L., Edelman, L. B., Boumendjel, R., Drasner, K., & Weinberg, G. L. (2010) · Regional Anesthesia & Pain Medicine · doi:10.1097/aap.0b013e3181c6f5aa · Cited by 70
The Effect of Lifestyle Changes in Non-Alcoholic Fatty Liver Disease
Centis, E., Marzocchi, R., Di Domizio, S., Ciaravella, M. F., & Marchesini, G. (2010) · Digestive Diseases · doi:10.1159/000282101 · Cited by 66
“In NAFLD patients, low-carbohydrate diets have been shown to influence hepatic triglyceride content via reduced de novo lipogenesis, which is selectively increased in NAFLD [”
BackgroundWang, Q., Li, S., Jiang, L., Zhou, Y., Li, Z., Shao, M., Li, W., & Liu, Y. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003335 · Cited by 67
Foster, M. T., Gentile, C. L., Cox‐York, K. A., Wei, Y., Wang, D., Estrada, A. L., Reese, L., Miller, T., Pagliassotti, M. J., & Weir, T. L. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500654 · Cited by 70
Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease
Lefere, S., Steenkiste, C. V., Verhelst, X., Vlierberghe, H. V., Devisscher, L., & Geerts, A. M. (2016) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2222-1 · Cited by 77
“And although hypoxia inhibits lipogenesis, lipogenic genes are upregulated in human NAFLD and play a central role in hepatic fat accumulation [101, 102].”
BackgroundThe Nutrient-Dependent O-GlcNAc Modification Controls the Expression of Liver Fatty Acid Synthase
Baldini, S. F., Wavelet, C. M., Hainault, I., Guinez, C., & Lefebvre, T. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.04.035 · Cited by 72
Yin, Y., Gao, L., Lin, H., Wu, Y., Han, X., Zhu, Y., & Li, J. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.11.101 · Cited by 78
Lee, H., Ahn, J., Shin, S. S., & Yoon, M. (2018) · International Journal of Obesity · doi:10.1038/s41366-018-0212-0 · Cited by 72
Sex-based differences in hepatic and skeletal muscle triglyceride storage and metabolism
Beaudry, K. M., & Devries, M. C. (2019) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2018-0635 · Cited by 65
“The excess IHTG stored in NAFLD is due to increased FA availability resulting from increased adipocyte FA release and increased DNL (Donnelly et al. 2005).”
BackgroundMonteillet, L., Gjorgjieva, M., Silva, M., Verzieux, V., Imikirene, L., Duchampt, A., Guillou, H., Mithieux, G., & Rajas, F. (2018) · Molecular Metabolism · doi:10.1016/j.molmet.2018.07.006 · Cited by 71
“It is noteworthy that in diabetes about 60% of TG accumulated in the liver of obese/diabetic patients originates from NEFA, 10% originating from the diet and almost 30% from de novo lipogenesis [45].”
BackgroundVisceral fat: A key mediator of NAFLD development and progression
Bansal, S., Vachher, M., Arora, T. K., Kumar, B., & Burman, A. (2023) · Human Nutrition & Metabolism · doi:10.1016/j.hnm.2023.200210 · Cited by 75
Valenti, L., Rametta, R., Ruscica, M., Dongiovanni, P., Steffani, L., Motta, B. M., Canavesi, E., Fracanzani, A. L., Mozzi, E., Roviaro, G., et al. (2012) · BMC Gastroenterology · doi:10.1186/1471-230x-12-111 · Cited by 69
“Increased lipolysis due to adipose tissue IR is key to NAFLD pathogenesis [5,7], and is associated with altered release of adipokines, and in particular adiponectin, a molecule with insulin-sensitizing, anti-inflammatory, and anti-fibrotic effects [8], whose decreased levels have been shown to correlate with hepatic f…”
BackgroundZhao, X., Xiaoli, Zong, H., Abdulla, A., Yang, E. S. T., Wang, Q., Ji, J., Pessin, J. E., Das, B. C., & Yang, F. (2014) · Diabetes · doi:10.2337/db13-0835 · Cited by 74
“Although fatty acids from diets and adipose tissue lipolysis support re-esterification in the liver to drive triglyceride synthesis, up to 30% of hepatic fatty acids are from de novo lipogenesis in NAFLD, but ,5% in normal individuals (5,6).”
BackgroundResistance to leptin action is the major determinant of hepatic triglyceride accumulation in vivo
Fishman, S., Muzumdar, R. H., Atzmon, G., Ma, X., Yang, X., Einstein, F. H., & Barzilai, N. (2007) · The FASEB Journal · doi:10.1096/fj.06-6557com · Cited by 70
“The hallmark feature, both histologically and metabolically, in the pathogenesis of NAFLD is the accumulation of triglycerides (TG) in the liver (2, 3).”
BackgroundThe Role of Fatty Acids in Non-Alcoholic Fatty Liver Disease Progression: An Update
Hliwa, A., Ramos‐Molina, B., Łaski, D., Mika, A., & Śledziński, T. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22136900 · Cited by 70
Dysregulation of hepatic metabolism with obesity: factors influencing glucose and lipid metabolism
Nagarajan, S. R., Cross, E., Sanna, F., & Hodson, L. (2021) · Proceedings of The Nutrition Society · doi:10.1017/s0029665121003761 · Cited by 71
“In the transition to the postprandial state, the relative contribution of plasma NEFA to VLDL-TAG is decreased (to between 28 and 57 % in lean and obese IS and IR individuals)((42,43,59,62)) due to the anti-lipolytic action of insulin on adipose tissue TAG((66)).”
InfluentialBays, H. E., Bindlish, S., & Clayton, T. L. (2023) · Obesity Pillars · doi:10.1016/j.obpill.2023.100056 · Cited by 74
“…origin of intra-organ lipids, in patients with obesity and nonalcoholic fatty liver disease, at least one study suggests that the origin of hepatic triglycerides were approximately 60% from circulating non-esteri fi ed free fatty acids, 25% from de novo lipogenesis, and 15% from the diet [62].”
BackgroundLee, S. A., & Riella, L. V. (2024) · Kidney International Reports · doi:10.1016/j.ekir.2024.02.1435 · Cited by 71
“101 The imbalance between lipogenesis and lipolysis results in the accumulation of free fatty acids within liver cells, causing hepatocellular damage, apoptosis, in fl ammation, and eventual fi brosis.”
BackgroundTanaka, N., Takahashi, S., Fang, Z., Matsubara, T., Krausz, K. W., Qu, A., & Gonzalez, F. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.08.015 · Cited by 71
“Furthermore, enhanced lipolysis in WAT and the predominance of FA use in the liver were also documented in humans having insulin resistance and NAFLD [16, 21].”
BackgroundFXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS
Maneschi, E., Vignozzi, L., Morelli, A., Mello, T., Filippi, S., Cellai, I., Comeglio, P., Sarchielli, E., Calcagno, A., Mazzanti, B., et al. (2013) · Journal of Endocrinology · doi:10.1530/joe-13-0109 · Cited by 68
“The major contributor to an increased triglyceride accumulation is dysfunctional AT (Donnelly et al. 2005).”
BackgroundNonalcoholic Fatty Liver Disease and Low-Carbohydrate Diets
York, L. W., Puthalapattu, S., & Wu, G. Y. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-070208-114232 · Cited by 68
Increased Dietary Substrate Delivery Alters Hepatic Fatty Acid Recycling in Healthy Men
Timlin, M. T., Barrows, B. R., & Parks, E. J. (2005) · Diabetes · doi:10.2337/diabetes.54.9.2694 · Cited by 67
“We have recently documented the contributions of multiple fatty acid sources to liver-TAG in patients with fatty liver (24).”
BackgroundSelf-citationSharma, R., Matsuzaka, T., Kaushik, M. K., Sugasawa, T., Ohno, H., Wang, Y., Motomura, K., Shimura, T., Okajima, Y., Mizunoe, Y., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-41631-1 · Cited by 71
Esler, W. P., Tesz, G. J., Hellerstein, M. K., Beysen, C., Sivamani, R. K., Turner, S., Watkins, S. M., Amor, P. A., Carvajal‐Gonzalez, S., Geoly, F. J., et al. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau8465 · Cited by 69
Moller, L., Stodkilde-Jorgensen, H., Jensen, F. T., & Jorgensen, J. O. L. (2008) · Clinical Science · doi:10.1042/cs20070217 · Cited by 70
Significance of Simple Steatosis: An Update on the Clinical and Molecular Evidence
Mazzolini, G. D., Sowa, J., Atorrasagasti, C., Kücükoglu, Ö., Syn, W., & Canbay, A. E. (2020) · Cells · doi:10.3390/cells9112458 · Cited by 71
“In NAFLD patients, 59% of FFA are derived from deregulated lipolysis in adipose tissue, while the remaining 26% come from hepatic DNL, and only 15% originate from the diet [64].”
BackgroundWilke, M. S., French, M. A., Goh, Y. K., Ryan, E. A., Jones, P. J. H., & Clandinin, M. T. (2009) · Diabetologia · doi:10.1007/s00125-009-1405-9 · Cited by 73
“Sources of FAs for hepatic TG synthesis are DNL, chylomicron remnant TG and plasma NEFAs, which vary depending on diet, feeding [11] and metabolic state [12].”
BackgroundHepatic free fatty acids accumulate in experimental steatohepatitis: Role of adaptive pathways
Larter, C. Z., Yeh, M. M., Haigh, W. G., Williams, J., Brown, S., Bell-Anderson, K. S., Lee, S. P., & Farrell, G. C. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2007.12.011 · Cited by 73
“In humans, up to 60% of hepatic lipids are derived from the periphery [29], and this contribution would likely be exacerbated in the lipodystrophic MCD model.”
BackgroundFatty Acid and Glucose Sensors in Hepatic Lipid Metabolism: Implications in NAFLD
Allison, M., Griffin, J., Vacca, M., & Vidal-Puig, A. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1562945 · Cited by 63
Siassi, F., Sotoudeh, G., Zolfaghari, H., Askari, G., & Feizi, A. (2016) · International Journal of Preventive Medicine · doi:10.4103/2008-7802.188083 · Cited by 77
“On the other hand, high carbohydrate level diets can affect NAFLD by influencing on de novo synthesis of fatty acids and increasing blood triglycerides.[4] Results of some other studies indicates a relation between type of lipid intake and developing this disease.”
BackgroundHomocysteine Induces Hepatic Steatosis Involving ER Stress Response in High Methionine Diet-Fed Mice
Ai, Y., Sun, Z., Peng, C. X., Liu, L., Xiao, X., & Li, J. (2017) · Nutrients · doi:10.3390/nu9040346 · Cited by 68
“It has been demonstrated that the plasma non-esterified fatty acid pool was the primary contributor to hepatic triglycerides [26].”
BackgroundGreuter, T., Malhi, H., Gores, G. J., & Shah, V. H. (2017) · JCI Insight · doi:10.1172/jci.insight.95354 · Cited by 67
Abnormal Myocardial Dietary Fatty Acid Metabolism and Diabetic Cardiomyopathy
Carpentier, A. C. (2018) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2017.12.029 · Cited by 71
Targeting mitochondria to oppose the progression of nonalcoholic fatty liver disease
Grattagliano, I., Montezinho, L. P., Oliveira, P. J., Frühbeck, G., Gómez‐Ambrosi, J., Montecucco, F., Carbone, F., Wieckowski, M. R., Wang, D. Q. ‐., & Portincasa, P. (2018) · Biochemical Pharmacology · doi:10.1016/j.bcp.2018.11.020 · Cited by 70
“Dietary and/or serum sugars enhances de novo lipogenesis [36] while insulin and glucose induce up-regulation of the carbohydrate-responsive element-”
BackgroundZhou, R., Yi, L., Ye, X., Zeng, X., Liu, K., Qin, Y., Zhang, Q., & Mi, M. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000495898 · Cited by 69
Pafili, K., Kahl, S., Mastrototaro, L., Strassburger, K., Pesta, D., Herder, C., Pützer, J., Dewidar, B., Hendlinger, M., Granata, C., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.010 · Cited by 67
“In the context of IR and fasting hypertriglyceridemia, circulating FFAs derived from AT lipolysis contribute to about 60% of hepatic triglyceride synthesis in overweight/obese humans with nonalcoholic fatty liver disease (NAFLD).(4) Recent studies suggest that AT dysfunction with increased lipogenic substrate flux may…”
BackgroundPromrat, K., Longato, L., Wands, J. R., & de la Monte, S. M. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2011.00815.x · Cited by 66
A “systems medicine” approach to the study of non-alcoholic fatty liver disease
Petta, S., Valenti, L. V. C., Bugianesi, E., Targher, G., Bellentani, S., Bonino, F., Ferrannini, E., Loguercio, C., Lonardo, A., Marra, F., et al. (2015) · Digestive and Liver Disease · doi:10.1016/j.dld.2015.10.027 · Cited by 70
“with smaller contributions from dietary fat and de novo lipogenesis [12–15].”
BackgroundObesity, insulin resistance and their interaction on liver enzymes
Liu, C., Shao, M., Lu, L., Zhao, C., Qiu, L., & Liu, Z. (2021) · PLoS ONE · doi:10.1371/journal.pone.0249299 · Cited by 74
“Individuals with obesity and NAFLD exhibit high levels of de novo lipogenesis (DNL) in both fasting and postprandial state [33, 34] and the anti-lipolytic effects of insulin are diminished by adipose tissue; that is, the rate of basal lypolysis in adipocytes is increased, which increase the delivery of fatty acids to…”
BackgroundThe Contribution of Dietary Fructose to Non-alcoholic Fatty Liver Disease
Yu, S., Li, C., Ji, G., & Zhang, L. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.783393 · Cited by 69
“More than a quarter of the intrahepatic lipid is generated by DNL in obese and NAFLD individuals (Donnelly et al., 2005; Lim et al., 2010).”
BackgroundLeptin Increases Hepatic Triglyceride Export via a Vagal Mechanism in Humans
Metz, M., Beghini, M., Wolf, P. S., Pfleger, L., Hackl, M. T., Bastian, M., Freudenthaler, A., Harreiter, J., Zeyda, M., Baumgartner-Parzer, S. M., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.09.020 · Cited by 70
Afolabi, O. K., Wusu, A. D., Ogunrinola, O. O., Abam, E. O., Babayemi, D. O., Dosumu, O. A., Onunkwor, B. O., Balogun, E. A., Odukoya, O. O., & Ademuyiwa, O. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0015-z · Cited by 66
Lee, M. J., Bağcı, P., Kong, J., Vos, M. B., Sharma, P., Kalb, B. T., Saltz, J. H., Martín, D. R., Adsay, V. N., & Farris, A. B. (2013) · Pathology - Research and Practice · doi:10.1016/j.prp.2013.04.001 · Cited by 67
Huang, B., Zhu, M.-F., Wu, T., Zhou, J.-Y., Liu, Y., Chen, X., Zhou, R.-F., Wang, L., Chen, Y., & Zhu, H. (2015) · PLoS ONE · doi:10.1371/journal.pone.0118071 · Cited by 72
“[42] reported that 59% of hepatic fat is derived from circulating FFAs, with lesser contributions from de novo lipogenesis (26%) and diet (15%), (2) inducing insulin resistance, which is thought to be related to the first “hit” in the multistep pathogenesis of non-alcoholic fatty liver disease, or (3) increasing oxida…”
BackgroundThe 5-lipoxygenase/leukotriene pathway in obesity, insulin resistance, and fatty liver disease
Martínez-Clemente, M., Clària, J., & Titos, E. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834777fa · Cited by 64
The Effect and Mechanism of Tamoxifen-Induced Hepatocyte Steatosis in Vitro
Zhao, F., Xie, P., Jiang, J., Zhang, L., An, W., & Zhan, Y. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms15034019 · Cited by 65
“Approximately 60% of liver TGs are derived from FFA influx from the adipose tissue; 25% are from DNL, and 15% are from diet [16].”
BackgroundNon‐alcoholic fatty liver disease: the role of nuclear receptors and circadian rhythmicity
Mazzoccoli, G., Vinciguerra, M., Oben, J. A., Tarquini, R., & Cosmo, S. D. (2014) · Liver International · doi:10.1111/liv.12534 · Cited by 70
“In healthy individuals, this source is a minor contributor while fasting and insulin levels are low (12).”
BackgroundInfluentialSommerweiss, D., Gorski, T., Richter, S., Garten, A., & Kieß, W. (2013) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2013.10.130 · Cited by 69
“The body handles excess FFA supply by storing it as intramyocellular and intrahepatic triglycerides [22, 23].”
BackgroundTreviño, S., Velázquez-Vázquez, D., Sánchez‐Lara, E., Díaz, A., Flores-Hernández, J. Á., Pérez-Benítez, A., Brambila, E., & Vergara, E. G. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/6058705 · Cited by 66
Silybin counteracts lipid excess and oxidative stress in cultured steatotic hepatic cells
Vecchione, G., Grasselli, E., Voci, A., Baldini, F., Grattagliano, I., Wang, D. Q. ‐., Portincasa, P., & Vergani, L. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i26.6016 · Cited by 69
Luo, H., Ming, J., Lian, G., Liu, Q., Shi, M., Li, T. Y., Song, L., Ye, J., He, Y., Yao, L., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.02.021 · Cited by 68
Liu, Q. K. (2021) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2021.05.007 · Cited by 60
Deng, Y., Chen, H., Huang, Y., Wang, Q., Chen, W., & Chen, D. (2022) · Environmental Science & Technology Letters · doi:10.1021/acs.estlett.2c00262 · Cited by 67
Han, C. Y., Ki, S. H., Kim, Y. W., Noh, K., Lee, D. Y., Kang, B., Ryu, J.-H., Jeon, R., Kim, E. H., Hwang, S. J., et al. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3190 · Cited by 63
“A line of evidence indicates that abnormal hepatic fat accumulation in NAFLD patients results largely from de novo lipogenesis (8, 45).”
Metadata
- Authors
- Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Parks, Elizabeth J.
- Venue
- Journal of Clinical Investigation
- Published
- 2005-05-02
- Volume
- 115
- Issue
- 5
- Pages
- 1343-1351
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1087172
- OpenAlex
- W1985592156
- Semantic Scholar
- ed7633369ab77ee37699d391fe0fa59627da0df8
- Cited by
- 3,604
- References
- 50
- Citations by year
- 2026: 158 · 2025: 199 · 2024: 230 · 2023: 268 · 2022: 254 · 2021: 264 · 2020: 229 · 2019: 221 · 2018: 222 · 2017: 184 · 2016: 200 · 2015: 185 · 2014: 163 · 2013: 147 · 2012: 127
- FWCI
- 44.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- American Diabetes Association
- University of Minnesota
- National Institutes of Health (RR00400)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK058286)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (PAR-98-086)
- National Center for Research Resources (M01RR000400)
- Topics
- Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipid metabolism and disorders
- Keywords
- non-alcoholic fatty liver disease, hepatic triglycerides, de novo lipogenesis, free fatty acids, VLDL, stable isotope tracers, fatty acid sources, hepatic lipid accumulation, obesity, hypertriglyceridemia, hyperinsulinemia
- MeSH terms
- Adult, Fatty Acids, Fatty Liver, Female, Humans, Lipoproteins, Liver, Male, Middle Aged, Time Factors, Triglycerides, Cholesterol, VLDL
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.